Strong Momentum With balanced ReturnsIt shows a more Robust BTST setup which cleaner breakout, confirmations across technical indicators Healios KK , is a promising candidate for BTST / INTRADAY
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.27 USD
−26.93 M USD
3.56 M USD
83.08 M
About Healios KK
Sector
Industry
CEO
Hardy T. S. Kagimoto
Website
Headquarters
Tokyo
Founded
2011
ISIN
JP3835100003
FIGI
BBG00TTG8BX0
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. It develops therapies for ischemic stroke, acute respiratory distress syndrome, liver disease, and age-regulated macular degeneration. The company was founded by Tadahisa Kagimoto on February 24, 2011 and is headquartered in Tokyo, Japan.
Related stocks
Cup and Handle Pattern 4593 heliosTSE:4593 When Will This Pattern Work?
For a Bullish Breakout (Ideal Condition):
Volume Surge:
A significant increase in volume above the 180 JPY resistance confirms buyer interest and potential breakout.
OBV Reversal:
OBV should start making higher highs, signaling accumulation.
CCI Recovery Above
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HLOSF is 2.50 USD — it has decreased by −26.47% in the past 24 hours. Watch HEALIOS K K stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange HEALIOS K K stocks are traded under the ticker HLOSF.
HLOSF stock has fallen by −26.47% compared to the previous week, the month change is a −26.47% fall, over the last year HEALIOS K K has showed a 85.19% increase.
We've gathered analysts' opinions on HEALIOS K K future price: according to them, HLOSF price has a max estimate of 4.67 USD and a min estimate of 3.31 USD. Watch HLOSF chart and read a more detailed HEALIOS K K stock forecast: see what analysts think of HEALIOS K K and suggest that you do with its stocks.
HLOSF reached its all-time high on Nov 9, 2020 with the price of 18.50 USD, and its all-time low was 0.93 USD and was reached on May 29, 2024. View more price dynamics on HLOSF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HLOSF stock is 36.00% volatile and has beta coefficient of 1.25. Track HEALIOS K K stock price on the chart and check out the list of the most volatile stocks — is HEALIOS K K there?
Today HEALIOS K K has the market capitalization of 316.24 M, it has increased by 2.62% over the last week.
Yes, you can track HEALIOS K K financials in yearly and quarterly reports right on TradingView.
HEALIOS K K is going to release the next earnings report on Feb 18, 2026. Keep track of upcoming events with our Earnings Calendar.
HLOSF earnings for the last quarter are 0.05 USD per share, whereas the estimation was 0.04 USD resulting in a 18.35% surprise. The estimated earnings for the next quarter are 0.00 USD per share. See more details about HEALIOS K K earnings.
HEALIOS K K revenue for the last quarter amounts to 128.44 K USD, despite the estimated figure of 5.68 M USD. In the next quarter, revenue is expected to reach 2.45 M USD.
HLOSF net income for the last quarter is 3.81 M USD, while the quarter before that showed −14.90 M USD of net income which accounts for 125.53% change. Track more HEALIOS K K financial stats to get the full picture.
No, HLOSF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 6, 2025, the company has 65 employees. See our rating of the largest employees — is HEALIOS K K on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HEALIOS K K EBITDA is −20.14 M USD, and current EBITDA margin is −465.18%. See more stats in HEALIOS K K financial statements.
Like other stocks, HLOSF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEALIOS K K stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEALIOS K K technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEALIOS K K stock shows the sell signal. See more of HEALIOS K K technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.